Table 2 Treatment modalities at baseline
Baseline parameters | Probiotic group (n = 68) | Placebo group (n = 68) | P value |
|---|---|---|---|
n (%) | n (%) | ||
Diet alone | 6 (8.8 %) | 1 (1.4 %) | 0.660 |
Single OAD | 19 (28.0 %) | 16 (23.6 %) | 0.589 |
Dual OAD | 37 (54.4 %) | 40 (58.8 %) | 0.912 |
>2 types OAD | 6 (8.8 %) | 11 (16.2 %) | 0.486 |
On Antihypertensive | 47 (69.2 %) | 48 (70.6 %) | 0.943 |
On Anti-hyperlipidemic | 54 (79.4 %) | 58 (85.4 %) | 0.610 |
Obesity | 18 (26.5 %) | 14 (20.6 %) | 0.419 |